NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹347 Cr | ₹317 Cr | ₹261 Cr | ₹237 Cr | ₹60 Cr |
What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹347 Cr |
| Mar2025 | ₹317 Cr |
| Mar2024 | ₹261 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹60 Cr |
How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹347 Cr | 9.22 | |
| Mar2025 | ₹317 Cr | 21.53 | |
| Mar2024 | ₹261 Cr | 10.10 | |
| Mar2023 | ₹237 Cr | 292.81 | |
| Mar2022 | ₹60 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,140.5 Cr | 2% | 4.4% | 34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2% |
4.4% |
34.1% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses